Pituitary-adrenal function after prolonged glucocorticoid therapy for systemic inflammatory disorders: An observational study

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 8, 2013, Pages 3199-3205

  Sacre, K ^a   Dehoux, M ^a   Chauveheid, M P ^a   Chauchard, M ^a   Lidove, O ^b   Roussel, R ^a   Papo, T ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b GROUPE HOSPITALIER DIACONESSES CROIX SAINT SIMON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; PREDNISONE; TETRACOSACTIDE;

ADRENAL INSUFFICIENCY; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; FRANCE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATORY DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SHORT SYNACTHEN TEST; SIDE EFFECT; SYSTEMIC INFLAMMATORY DISEASE;

ADRENAL INSUFFICIENCY; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; INFLAMMATION; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; PREDNISONE; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 84881537941     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1394     Document Type: Article

References (27)

1. van Staa TP, Leufkens HG, Abenhaim L, Begaud B, Zhang B, Cooper C. Use of oral corticosteroids in the United Kingdom. QJM. 2000;93:105-111.
2. Bornstein SR. Predisposing factors for adrenal insufficiency.NEngl J Med. 2009;360:2328-2339.
3. Schlaghecke R, Kornely E, Santen RT, Ridderskamp P. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med. 1992; 326:226-230.
4. Livanou T, Ferriman D, James VH. Recovery of hypothalamo-pituitary- adrenal function after corticosteroid therapy. Lancet. 1967; 2:856-859.
5. Robinson BH, Mattingly D, Cope CL. Adrenal function after prolonged corticosteroid therapy. Br Med J. 1962;1:1579-1584.
6. Jasani MK, Boyle JA, Greig WR, et al. Corticosteroid-induced suppression of the hypothalamo-pituitary-adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis. QJM. 1967;36:261-276.
7. LaRochelle GE Jr, LaRochelle AG, Ratner RE, Borenstein DG. Recovery of the hypothalamic-pituitary-adrenal (HPA) axis in patients with rheumatic diseases receiving low-dose prednisone. Am J Med. 1993;95:258-264.
8. Krasner AS. Glucocorticoid-induced adrenal insufficiency. JAMA. 1999;282:671-676.
9. Oelkers W. Adrenal insufficiency. N Engl J Med. 1996;335:1206-1212.
10. Arlt W, Allolio B. Adrenal insufficiency. Lancet. 2003;361:1881-1893.
11. Agha A, Tomlinson JW, Clark PM, Holder G, Stewart PM. The long-term predictive accuracy of the short Synacthen (corticotropin) stimulation test for assessment of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab. 2006;91:43-47.
12. Grinspoon SK, Biller BM. Clinical review 62: Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab. 1994;79: 923-931.
13. Chitale A, Musonda P, McGregor AM, Dhatariya KK. 2012 Determining the utility of the 60 min cortisol measurement in the short Synacthen test. Clin Endocrinol (Oxf). 2013;79:14-19
14. Le Roux CW, Meeran K, Alaghband-Zadeh J. Is a 0900-h serum cortisol useful prior to a short Synacthen test in outpatient assessment? Ann Clin Biochem. 2002;39:148-150.
15. Patel SR, Selby C, Jeffcoate WJ. The short Synacthen test in acute hospital admissions. Clin Endocrinol (Oxf). 1991;35:259-261.
16. Clark PM, Neylon I, Raggatt PR, Sheppard MC, Stewart PM. Defining the normal cortisol response to the short Synacthen test: implications for the investigation of hypothalamic-pituitary disorders. Clin Endocrinol (Oxf). 1998;49:287-292.
17. Dorin RI, Qualls CR, Crapo LM. Diagnosis of adrenal insufficiency. Ann Intern Med. 2003;139:194-204.
18. Endert E, Ouwehand A, Fliers E, Prummel MF, Wiersinga WM. Establishment of reference values for endocrine tests. Part IV: Adrenal insufficiency. Neth J Med. 2005;63:435-443.
19. Klose M, Lange M, Rasmussen AK, et al. Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents. J Clin Endocrinol Metab. 2007;92:1326-1333.
20. El-Farhan N, Pickett A, Ducroq D, et al. Method-specific serum cortisol responses to the adrenocorticotrophin test: comparison of gas chromatography-mass spectrometry and five automated immunoassays. Clin Endocrinol (Oxf). 2013;78:673-680.
21. Graber AL, Ney RL, Nicholson WE, Island DP, Liddle GW. Natural History of Pituitary-Adrenal Recovery Following Long-Term Suppression with Corticosteroids. J Clin Endocrinol Metab. 1965;25: 11-16.
22. Hahner S, Loeffler M, Bleicken B, et al. Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. Eur J Endocrinol. 2010;162:597-602.
23. Stewart PM, Corrie J, Seckl JR, Edwards CR, Padfield PL. Arational approach for assessing the hypothalamo-pituitary-adrenal axis. Lancet. 1988;1:1208-1210.
24. Hagg E, Asplund K, Lithner F. Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency. Clin Endocrinol (Oxf). 1987;26:221-226.
25. Gleeson HK, Walker BR, Seckl JR, Padfield PL. Ten years on: Safety of short Synacthen tests in assessing adrenocorticotropin deficiency in clinical practice. J Clin Endocrinol Metab. 2003;88:2106-2111.
26. Lindholm J, Kehlet H. Re-evaluation of the clinical value of the 30 min ACTH test in assessing the hypothalamic-pituitary-adrenocortical function. Clin Endocrinol (Oxf). 1987;26:53-59.
27. Chatha KK, Middle JG, Kilpatrick ES. National UK audit of the short Synacthen test. Ann Clin Biochem. 2010;47:158-164.